-
Mashup Score: 0
NEW ORLEANS — In this video exclusive, Jonathan D. Leffert, MD, talks with Scott D. Isaacs, MD, FACP, FACE, and Sangeeta Kashyap, MD, about nomenclature for liver disease and how endocrinologists should approach screening and treatment.Leffert is managing partner at North Texas Endocrine Center, a past president of the American Association of Clinical Endocrinology and a Healio | Endocrine
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 2More energy means more family fun - 2 hour(s) ago
When Denisse, a single mom of 3 kids, found out about the National Diabetes Prevention Program, she needed help. She had no energy, she was depressed, and he…
Source: www.youtube.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 0ECE 2024 Nurse Programme | ESE - 2 hour(s) ago
The ESE Nurse Committee is once again planning an engaging and informative programme tailored specifically to nurses. The Nurses Pre-Congress Course will take place on Saturday 11 May 2024, with the main Nurses Congress programme following on Sunday 12 May. Please see the following overview letter from Sherwin Criseno, Chair of the ESE Nurse Committee, which gives some further insight as to what you can expect at ECE
Source: www.ese-hormones.orgCategories: General Medicine News, EndocrinologyTweet-
Ahead of our pre-Congress Nurses' course which starts tomorrow, we wish to celebrate our endocrine nurse community across Europe on #IND2024. We have a full Nurse Programme at ECE 2024, which you can join via ECE@Home 👉 https://t.co/udusENBbj1 #nurses #ECE2024 @CrisenoSherwin https://t.co/u1SmwJ6Ekh
-
-
Mashup Score: 2Effect of population-wide screening for presymptomatic early-stage type 1 diabetes on paediatric clinical care - 3 hour(s) ago
Population-wide screening of children for presymptomatic early-stage type 1 diabetes is gaining momentum. Studies have demonstrated feasibility and acceptance, and shown that the rate of progression to clinical stage 3 diabetes is similar if islet autoantibody-positive early-stage type 1 diabetes is identified from general population or first-degree relative screening.1,2 Moreover, in conjunction with an education and follow-up package, screening significantly reduces the rates of ketoacidosis, symptoms, and hospitalisation.
Source: www.thelancet.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 1The CO-CREATE EU project launches a new Youth Advocacy Toolkit | World Obesity Federation - 4 hour(s) ago
The launch took place during a webinar event to explore CO-CREATE’s aims and research, and how to use the Toolkit.
Source: www.worldobesity.orgCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 3Heterozygous gain of function variant in GUCY1A2 may cause autonomous ovarian hyperfunction - 5 hour(s) ago
AbstractPurpose. The purpose of this study was to characterize the phenotype associated with a de novo gain-of-function variant in the GUCY1A2 gene.Methods
Source: academic.oup.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 4World Obesity Federation Global Obesity Observatory - 6 hour(s) ago
At the World Obesity Federation we have been collating data for over 20 years. This database is online and available to view in various formats.
Source: data.worldobesity.orgCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 4
In pregnant women starting with tighter glycaemic control, AHCL therapy did not improve overall time in target range but improved overnight time in target range, reduced time below range, and improved treatment satisfaction. These data suggest that the MiniMed 780G can be safely used in pregnancy and provides some additional benefits compared with standard insulin therapy; however, it will be important to refine the algorithm to better align with pregnancy requirements.
Source: www.thelancet.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 0Demarcating the benefits of hybrid closed loop therapy in pregnant women with type 1 diabetes - 6 hour(s) ago
The role of hybrid closed-loop systems in the clinical management of type 1 diabetes is rapidly expanding. Randomised controlled trials have shown life-changing clinical and quality-of-life benefits beyond those that can be obtained by use of continuous glucose monitoring (CGM) with an insulin pump or multiple daily injection therapy.1 Meta-analyses of trial data confirm substantial glycaemic improvements in people of all ages, with 8–12 percentage points higher time spent in the target glucose range of 3·9–10·0 mmol/L, and lower mean glucose with less or no additional hypoglycaemia.
Source: www.thelancet.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 0
With the increase in obesity prevalence worldwide, considerable efforts have been made to investigate the molecular and neurohormonal mechanisms of bodyweight control, as a means to identify novel therapeutic targets. As a paradigmatic example, characterisation of the physiological actions of glucagon-like peptide-1 (GLP-1) paved the way for development of long-acting GLP-1 analogues that are revolutionising the pharmacological management of obesity.1 Similarly, recognition of the fundamental roles of the leptin–melanocortin system in bodyweight homeostasis has opened up potential pathways to manage some forms of obesity.
Source: www.thelancet.comCategories: General Medicine News, EndocrinologyTweet
▶️ In this video, @JonathanLeffert speaks with @scottisaacsmd and Sangeeta Kashyap about treating metabolic dysfunction-associated steatotic liver disease or MASLD. ⚕️ #AACE2024 @TheAACE https://t.co/PwYWbO4PNV